These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18449413)

  • 1. Recombinant clotting factors.
    Pipe SW
    Thromb Haemost; 2008 May; 99(5):840-50. PubMed ID: 18449413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise and challenges of bioengineered recombinant clotting factors.
    Pipe SW
    J Thromb Haemost; 2005 Aug; 3(8):1692-701. PubMed ID: 16102035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
    Duan X; Tang M; Zhang J; Yu H; Xu R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test.
    Mathieu S; Crampe C; Dargaud Y; Lavigne-Lissalde G; Escuriola-Ettingshausen C; Tardy B; Meley R; Thouvenin S; Stephan JL; Berger C
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):940-5. PubMed ID: 26517064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the treatment of pediatric hemophilia and bleeding disorders.
    Branchford BR; Monahan PE; Di Paola J
    Curr Opin Pediatr; 2013 Feb; 25(1):23-30. PubMed ID: 23274430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The past and future of haemophilia: diagnosis, treatments, and its complications.
    Peyvandi F; Garagiola I; Young G
    Lancet; 2016 Jul; 388(10040):187-97. PubMed ID: 26897598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the treatment of bleeding disorders.
    Bergman GE
    Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous inhibitors to coagulation factors.
    Green D
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for administration of fresh frozen plasma and clotting factor concentrates.
    Muntean W
    Acta Anaesthesiol Scand Suppl; 1996; 109():139-41. PubMed ID: 8901985
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders.
    United Kingdom Haemophelia Centre Doctors' Organisation
    Haemophilia; 2003 Jan; 9(1):1-23. PubMed ID: 12558775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
    Mancuso ME; Mahlangu JN; Pipe SW
    Lancet; 2021 Feb; 397(10274):630-640. PubMed ID: 33460559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of clotting factor therapy.
    Berntorp E; Björkman S
    Haemophilia; 2003 Jul; 9(4):353-9. PubMed ID: 12828668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A. A critical literature review.
    Franchini M; Lippi G
    Thromb Haemost; 2010 Nov; 104(5):931-40. PubMed ID: 20838738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel products for haemostasis - current status.
    Oldenburg J; Albert T
    Haemophilia; 2014 May; 20 Suppl 4():23-8. PubMed ID: 24762271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hope and reality of long-acting hemophilia products.
    Pipe SW
    Am J Hematol; 2012 May; 87 Suppl 1():S33-9. PubMed ID: 22389200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia.
    Schaub RG
    Biochem Pharmacol; 2011 Jul; 82(2):91-8. PubMed ID: 21453683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
    Johansen RF; Sørensen B; Ingerslev J
    Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of recombinant coagulation proteins.
    Vehar GA
    Ann N Y Acad Sci; 1987; 509():82-8. PubMed ID: 3122622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.